Genzyme Corp., Biogen Inc. and Abbott Bioresearch Center filed suit earlier this summer against Columbia University in the U.S. District Court of Massachusetts, claiming that a new patent issued to the university in September 2002 that centered on cotransformation technology was "invalid and unenforceable." (BioWorld Financial Watch) Read More
